Iterum Therapeutics (ITRM)
NASDAQ: ITRM
· Real-Time Price · USD
0.76
-0.07 (-8.52%)
At close: Aug 20, 2025, 3:59 PM
0.75
-1.28%
Pre-market: Aug 21, 2025, 05:43 AM EDT
Iterum Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 2.62M | 2.62M | 2.62M | 2.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.28M | 589K | 254K | 455K | 891K | 1.32M | 1.75M | 1.75M | 1.76M | 1.78M | 1.8M | 3.13M | 2.8M | 2.53M | 2.07M | 296K | 185K | n/a |
Gross Profit | -1.28M | -589K | -254K | -455K | -891K | -1.32M | -1.75M | -1.75M | -1.76M | -1.78M | -1.8M | -3.13M | -2.8M | -2.53M | -2.1M | -331K | -220K | -35K |
Operating Income | -17.8M | -16.24M | -18.7M | -26.46M | -38.26M | -45.1M | -47.47M | -43.96M | -34.31M | -31.54M | -30.38M | -29.29M | -27.13M | -26.06M | -24.54M | -22.35M | -23.81M | -25.08M |
Interest Income | 133K | n/a | n/a | n/a | n/a | 324.00 | 723.00 | 803.00 | 1.44K | 1.11K | 716.00 | 636.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -23.8M | -22.31M | -24.53M | -30.2M | -27.95M | -35.05M | -37.76M | -30.53M | -56.49M | -50.83M | -44.13M | -43.16M | -9.38M | 4.93M | -90.86M | -98.01M | -113.88M | -134.15M |
Net Income | -24.08M | -22.56M | -24.77M | -30.55M | -28.34M | -35.58M | -38.37M | -31.1M | -56.33M | -50.82M | -44.43M | -43.53M | -10.68M | 3.86M | -91.56M | -98.57M | -114.51M | -134.83M |
Selling & General & Admin | 10.86M | 8.57M | 7.98M | 7.55M | 7.61M | 7.56M | 7.48M | 7.88M | 8.72M | 10.93M | 12.77M | 13.81M | 14.15M | 14.36M | 13.82M | 12.99M | 12.36M | 11.3M |
Research & Development | 5.65M | 7.08M | 10.46M | 18.46M | 30.2M | 37.09M | 39.55M | 36.09M | 25.59M | 20.61M | 17.62M | 15.48M | 12.97M | 11.7M | 10.71M | 9.36M | 11.45M | 13.78M |
Other Expenses | n/a | n/a | -17K | -96K | -26K | 24K | 82K | 58K | -17.19M | -16.97M | -16.85M | -16.72M | 492K | 316K | 195K | 167K | 134K | 38K |
Operating Expenses | 16.51M | 15.65M | 18.44M | 26.01M | 37.81M | 44.65M | 47.03M | 43.96M | 34.31M | 31.54M | 30.38M | 29.29M | 27.13M | 26.06M | 24.54M | 22.35M | 23.81M | 25.08M |
Interest Expense | -2.6M | -2.48M | -2.52M | 2.05M | 1.76M | 1.52M | 1.43M | 1.02M | 1.36M | 1.8M | 2.44M | 3.21M | 3.43M | 3.64M | 5.55M | 9.02M | 12.36M | 15.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.8M | 16.24M | 18.7M | 26.46M | 38.26M | 45.1M | 47.47M | 43.96M | 34.31M | 31.54M | 30.38M | 29.29M | 27.13M | 26.06M | 24.54M | 22.35M | 23.81M | 25.08M |
Income Tax Expense | 280K | 252K | 240K | 357K | 382K | 538K | 613K | 572K | -159K | -3K | 301K | 371K | 1.29M | 1.07M | 705K | 558K | 626K | 682K |
Shares Outstanding (Basic) | 39.94M | 34.06M | 19.7M | 20.04M | 16.55M | 15.43M | 13.18M | 13.04M | 12.94M | 12.68M | 13.34M | 12.23M | 12.22M | 13.23M | 13.22M | 12.18M | 13.02M | 8.79M |
Shares Outstanding (Diluted) | 39.94M | 34.06M | 19.7M | 20.04M | 16.55M | 15.43M | 13.18M | 13.04M | 12.94M | 12.68M | 13.34M | 12.23M | 12.22M | 12.19M | 13.22M | 13.48M | 13.64M | 8.1M |
EPS (Basic) | -0.85 | -0.99 | -1.31 | -2 | -2 | -2.65 | -2.97 | -2.44 | -4.52 | -4.12 | -3.63 | -3.56 | -0.89 | 0.26 | -11.66 | -15.45 | -24.04 | -35.7 |
EPS (Diluted) | -0.85 | -0.99 | -1.31 | -2 | -2 | -2.65 | -2.97 | -2.44 | -4.52 | -4.12 | -3.63 | -3.56 | -0.9 | 0.20 | -10.71 | -14.5 | -23.08 | -34.69 |
EBITDA | -20.38M | -19.12M | -21.73M | -27.68M | -25.3M | -32.21M | -34.58M | -27.84M | -53.45M | -47.33M | -39.97M | -36.81M | -3.16M | 11.1M | -83.2M | -88.62M | -101.22M | -118.53M |
EBIT | -21.35M | -19.74M | -22.01M | -28.14M | -26.19M | -33.53M | -36.33M | -29.5M | -55.13M | -49.02M | -41.69M | -39.94M | -5.96M | 8.57M | -85.31M | -88.99M | -101.52M | -118.69M |
Depreciation & Amortization | 969K | 626K | 284K | 463K | 891K | 1.32M | 1.75M | 1.75M | 1.76M | 1.78M | 1.8M | 3.13M | 2.8M | 2.53M | 2.1M | 370K | 303K | 157K |